Matches in Nanopublications for { ?s ?p "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP902862.RADohoXdI28eieLr4EL8Emgnu-X06sRQqJaYoOhqLakDE130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902862.RADohoXdI28eieLr4EL8Emgnu-X06sRQqJaYoOhqLakDE130_provenance.
- NP208427.RAU4buCi8cy7YXKGghLW9fEsFrr1yXMBtNtqXTlqf7lRs130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208427.RAU4buCi8cy7YXKGghLW9fEsFrr1yXMBtNtqXTlqf7lRs130_provenance.
- NP557773.RAZCt7QGbPNGooVB6gsVHoNeYvSekSSBdp5umGGCbzsuo130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557773.RAZCt7QGbPNGooVB6gsVHoNeYvSekSSBdp5umGGCbzsuo130_provenance.
- NP639573.RAYzp2ADW3jhTNE4rmBTkJnDIXxYU_veac9YJC_RzzNuM130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639573.RAYzp2ADW3jhTNE4rmBTkJnDIXxYU_veac9YJC_RzzNuM130_provenance.
- NP667591.RAfsutjHqd5yIdfOEQlvnoHKN3tck6WlPNJkf3_jFjdk4130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667591.RAfsutjHqd5yIdfOEQlvnoHKN3tck6WlPNJkf3_jFjdk4130_provenance.
- NP931480.RAcvkJCP0aMoxaLVshZX60hqzerlbre88PJIFNcfcNeyI130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931480.RAcvkJCP0aMoxaLVshZX60hqzerlbre88PJIFNcfcNeyI130_provenance.
- NP523102.RAAsT67ROQR_I_boab91E-7nS4nh9lIHevB-kWTiZt_38130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523102.RAAsT67ROQR_I_boab91E-7nS4nh9lIHevB-kWTiZt_38130_provenance.
- NP523104.RAm4W6Rue1guWuPwbH8SXLTV_rjHmleIB4A_u8WmUI9xY130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523104.RAm4W6Rue1guWuPwbH8SXLTV_rjHmleIB4A_u8WmUI9xY130_provenance.
- NP523103.RAKsfQH8-p7uVcs2HyrhXzQXGL0bH3Ae4x4EezR3y_0fk130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523103.RAKsfQH8-p7uVcs2HyrhXzQXGL0bH3Ae4x4EezR3y_0fk130_provenance.
- NP523106.RA4wGrJvjSmMt7ZSzdqaFk_gWxVSuzB-7bMdsWoHAzRbc130_assertion description "[We examined loss of heterozygosity (LOH) at the TP53 gene in primary human endometrial carcinomas (EC), and investigated the relationship between allelic loss, p53 protein overexpression, pRb-1 pathway alterations and MIB-1 proliferative activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523106.RA4wGrJvjSmMt7ZSzdqaFk_gWxVSuzB-7bMdsWoHAzRbc130_provenance.